Argyria: Ocular Findings

Argyria is a permanent, blue-gray discoloration of the skin and mucous membranes caused by chronic deposition of silver particles in tissue.

When it involves the eye — a condition sometimes distinguished by the more specific term argyrosis when referring specifically to ocular tissue deposition — it produces a slate-gray discoloration of the conjunctiva that is cosmetically permanent but harmless to vision, making patient reassurance and identification of the silver source the two central tasks once the diagnosis is recognized.

Sources of Silver Exposure

Colloidal silver dietary supplements — probably the most common cause encountered in current clinical practice, taken by patients as an unproven alternative remedy for various presumed health benefits, often without recognizing the risk of permanent discoloration until it has already occurred
Occupational exposure — silver refining, photographic processing (historically more relevant given the shift to digital photography), and certain other industrial processes
Silver-containing nasal sprays or other topical/mucosal silver-containing products used chronically
Silver-containing dental amalgams or other dental materials, in rare cases
Historical medicinal use of silver-containing compounds (silver nitrate, colloidal silver preparations) that were once more commonly used therapeutically before their permanent cosmetic risk was as well recognized as it is today

Mechanism

Silver, once absorbed systemically, is deposited in tissues throughout the body, with the skin, mucous membranes, and eye being sites where the deposited particles are most visibly apparent given their proximity to the surface and the specific tissue characteristics that favor silver binding and retention.

In the eye specifically, silver deposits in the conjunctiva and, less commonly, in deeper ocular structures, producing the characteristic slate-gray to blue-gray discoloration.

Unlike some other causes of tissue pigmentation, this change is essentially permanent once it has occurred, because the body has no effective mechanism to clear deposited silver particles from tissue.

This permanence is an important point to establish clearly with the patient at diagnosis, since it sets realistic expectations from the outset and avoids the disappointment of a patient later discovering, after stopping the exposure, that the visible discoloration has not resolved as they may have hoped.

Clinical Findings

Diffuse, slate-gray to blue-gray discoloration of the conjunctiva, often most visible in the interpalpebral zone, similar in general distribution pattern to some other causes of conjunctival or scleral pigmentation discussed elsewhere on this site
Generalized skin discoloration in more widespread systemic argyria, typically most visible on sun-exposed skin (since UV light appears to accelerate the deposited silver’s characteristic color change), giving affected individuals a distinctive, permanently blue-gray complexion
The ocular finding does not typically affect visual acuity or cause other functional ocular impairment, distinguishing its clinical significance sharply from many other pigmentary or deposition disorders that can threaten vision
Corneal involvement (silver deposition in Descemet’s membrane, producing a picture that can resemble the Kayser-Fleischer ring of Wilson’s disease) has been reported in some cases of more significant exposure, though conjunctival involvement is more commonly the presenting or most visible finding

Differential Diagnosis

Alkaptonuria (ochronosis) — scleral rather than primarily conjunctival pigmentation, from an inherited metabolic disorder rather than an exogenous exposure, discussed in its own dedicated article on this site; the two conditions can be distinguished by history (a silver exposure source versus no such history) and by the specific pattern and tissue depth of pigmentation
Kayser-Fleischer ring (Wilson’s disease) — copper rather than silver deposition, specifically in Descemet’s membrane at the corneal periphery rather than diffuse conjunctival involvement, discussed in this site’s coverage of Wilson’s disease-related corneal and lens findings
Racial/ethnic conjunctival or scleral pigmentation — a normal anatomic variant present from birth, without a relevant exposure history or the specific diffuse, generalized quality of argyria-related pigmentation
Adrenal insufficiency-related pigmentation — a different mechanism (excess ACTH-driven melanocyte stimulation) with its own distinct systemic features, distinguishing it from the exogenous, exposure-related mechanism of argyria

Diagnostic Evaluation

The diagnosis is usually straightforward once a relevant silver exposure history — colloidal silver supplement use, which patients may not think to mention unless specifically asked — is identified alongside the characteristic clinical appearance.

A careful medication and supplement history, specifically asking about “natural” or alternative remedies, is often what actually uncovers the causative exposure, because patients frequently do not consider an over-the-counter supplement worth mentioning as a “medication” when asked more generally about drug use, a gap in routine history-taking worth actively correcting.

Management

There is no effective treatment to reverse established argyria or ocular argyrosis once silver has deposited in tissue.

Management is limited to discontinuing the ongoing source of silver exposure to prevent further accumulation and progression, and to counseling the patient that existing discoloration is permanent.

Because the condition is cosmetically permanent but medically benign, the most important practical intervention is often identifying and stopping the causative exposure — relevant given how many cases stem from an unproven, self-directed supplement use that the patient may otherwise continue indefinitely without realizing the connection to their skin or eye changes.

Sensitive, non-judgmental counseling about the underlying source of exposure — particularly when it involves an alternative remedy the patient believed was harmless or even beneficial — supports genuine behavior change far better than simply informing the patient that the discoloration cannot be reversed.

References

Wadhera A, Fung M. Systemic argyria associated with ingestion of colloidal silver. Dermatology Online Journal.
Gaul LE, Staud AH. Clinical spectrum of generalized argyria following organic and colloidal silver medication. Journal of the American Medical Association.
American Academy of Ophthalmology. Basic and Clinical Science Course, Section 8: External Disease and Cornea.

Argyria: The Permanent Gray Eye From Colloidal Silver